TRH Financial LLC purchased a new position in UnitedHealth Group Inc (NYSE:UNH) during the 3rd quarter, Holdings Channel reports. The institutional investor purchased 676 shares of the healthcare conglomerate’s stock, valued at approximately $211,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 7.5% in the second quarter. Vanguard Group Inc. now owns 80,727,140 shares of the healthcare conglomerate’s stock worth $23,810,470,000 after purchasing an additional 5,654,194 shares during the last quarter. State Street Corp grew its holdings in UnitedHealth Group by 0.5% in the first quarter. State Street Corp now owns 46,003,796 shares of the healthcare conglomerate’s stock worth $11,472,427,000 after purchasing an additional 212,240 shares during the last quarter. Nuveen Asset Management LLC grew its holdings in UnitedHealth Group by 4.4% in the second quarter. Nuveen Asset Management LLC now owns 7,294,171 shares of the healthcare conglomerate’s stock worth $2,151,416,000 after purchasing an additional 305,797 shares during the last quarter. Sanders Capital LLC lifted its stake in shares of UnitedHealth Group by 3.3% during the second quarter. Sanders Capital LLC now owns 5,422,137 shares of the healthcare conglomerate’s stock worth $1,787,646,000 after buying an additional 172,998 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 0.8% during the second quarter. Charles Schwab Investment Management Inc. now owns 4,794,237 shares of the healthcare conglomerate’s stock worth $1,414,060,000 after buying an additional 39,532 shares during the period. 86.39% of the stock is currently owned by institutional investors and hedge funds.

In related news, EVP Marianne D. Short sold 12,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $321.34, for a total transaction of $3,856,080.00. Following the completion of the sale, the executive vice president now owns 140,885 shares of the company’s stock, valued at approximately $45,271,985.90. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 22nd. The shares were sold at an average price of $303.50, for a total transaction of $3,035,000.00. Following the sale, the director now directly owns 159,215 shares of the company’s stock, valued at approximately $48,321,752.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 47,336 shares of company stock valued at $14,928,276. 0.80% of the stock is owned by corporate insiders.

Several equities research analysts have recently commented on UNH shares. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a research note on Thursday. Credit Suisse Group set a $335.00 price objective on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Wednesday. ValuEngine upgraded shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Thursday, October 1st. Piper Sandler lifted their price objective on shares of UnitedHealth Group from $350.00 to $385.00 and gave the stock an “overweight” rating in a research note on Thursday. Finally, Stephens lifted their price objective on shares of UnitedHealth Group from $325.00 to $335.00 and gave the stock an “overweight” rating in a research note on Thursday, July 16th. Four investment analysts have rated the stock with a hold rating, twenty-one have given a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $346.68.

UNH stock opened at $329.90 on Friday. The stock has a market capitalization of $313.52 billion, a P/E ratio of 18.55, a P/E/G ratio of 1.44 and a beta of 0.68. The firm has a 50-day simple moving average of $311.35 and a 200-day simple moving average of $297.69. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 0.60. UnitedHealth Group Inc has a 52 week low of $187.72 and a 52 week high of $333.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Monday, October 19th. The healthcare conglomerate reported $3.51 EPS for the quarter, topping analysts’ consensus estimates of $2.98 by $0.53. The business had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. UnitedHealth Group had a net margin of 6.90% and a return on equity of 29.28%. The company’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.88 earnings per share. On average, analysts expect that UnitedHealth Group Inc will post 16.58 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Friday, September 11th. This represents a $5.00 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Outstanding Shares, Buying and Selling Stocks

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.